According to the American Health announcement, Hangzhou Haoyue Enterprise Management Co., Ltd., a shareholder of more than 5%, reduced its holdings by a total of 35.759 million shares through centralized bidding and bulk transactions from July 27 to August 13, 2026, by a reduction ratio of 0.91%. After the holdings were reduced, the total shareholding ratio of Hangzhou Haoyue and its co-actors fell from 7.91% to 7.00%. This reduction in holdings will not lead to a change in the company's control, will not affect sustainable operations, and is consistent with the previous holdings reduction plan, and the holdings reduction plan has not yet been implemented.

According to the American Health announcement, Hangzhou Haoyue Enterprise Management Co., Ltd., a shareholder of more than 5%, reduced its holdings by a total of 35.759 million shares through centralized bidding and bulk transactions from July 27 to August 13, 2026, by a reduction ratio of 0.91%. After the holdings were reduced, the total shareholding ratio of Hangzhou Haoyue and its co-actors fell from 7.91% to 7.00%. This reduction in holdings will not lead to a change in the company's control, will not affect sustainable operations, and is consistent with the previous holdings reduction plan, and the holdings reduction plan has not yet been implemented.